Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of HFpEF
TRAINING-HF
1 other identifier
interventional
52
1 country
1
Brief Summary
Heart failure (HF) with preserved ejection fraction (HFpEF) has become the most prevalent form of HF in developed countries. Despite its increasing in prevalence, there is no evidence-based effective therapy for HFpEF The purpose of this study was to evaluate whether inspiratory muscle training (IMT), functional electrical stimulation (FES), or combination of both improve exercise capacity as well as left ventricular diastolic function, biomarkers' profile, quality of life (QoL) and prognosis in patients with HFpEF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2015
CompletedFirst Submitted
Initial submission to the registry
December 1, 2015
CompletedFirst Posted
Study publicly available on registry
December 23, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2017
CompletedMay 18, 2017
May 1, 2017
1.3 years
December 1, 2015
May 17, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Functional capacity measured as peak oxygen uptake (peak VO2) in ml/min/kg .
Maximal functional capacity will be evaluated with an incremental and symptom-limited cardiopulmonary exercise testing (CORTEX Metamax 3B) on a bicycle ergometer, beginning with a workload of 10 W and increasing stepwise at 10-W increments every 1 min. During exercise, patients were continuously monitored with twelve-lead electrocardiogram and blood pressure measurements every 2 min. Gas exchange data and cardiopulmonary variables were averaged every 10 seconds values. Peak VO2 is considered the highest value of VO2 during the last 20 s of exercise. The improvement \> of 10% in peak VO2 will be considered clinically meaningful
changes at 12 weeks and 6 months
Secondary Outcomes (6)
Functional capacity measured as distance walked in 6 minutes
changes at 12 weeks and 6 months
Change in echocardiographic parameter of diastolic disfunction: e' septal (cm/s)
changes in rest at 12 weeks and 6 months
Change in echocardiographic parameter of diastolic disfunction: left atrial volume index (mm/m2)
changes in rest at 12 weeks and 6 months
Change in echocardiographic parameter of diastolic disfunction: E/e' ratio
changes in rest at 12 weeks and 6 months
Change in health-related QoL
changes at 12 weeks and 6 months
- +1 more secondary outcomes
Study Arms (4)
Standard treatment
PLACEBO COMPARATOROnly standard medical treatment
IMT group
ACTIVE COMPARATORStandard medical treatment associated to Inspiratory muscle training
FES group
ACTIVE COMPARATORStandard medical treatment associated to functional electrostimulation of both legs for 45 minutes a day, 2 days per week for a total of 12 weeks.
IMT+FES group
ACTIVE COMPARATORStandard medical treatment associated to combination of inspiratory muscle training and functional electrostimulation of both legs
Interventions
Patients allocated to IMT arm will receive standard medical treatment and will be instructed to train at home twice daily, for 20 minutes each session, and during 12 weeks using a threshold inspiratory muscle trainer (Threshold IMT®, Respironics Inc.). All of them will be instructed by a respiratory therapist and educated to maintain a diaphragmatic breathing during the training period. The subjects start breathing at a resistance equal to 25-30% of their maximal inspiratory pressure (MIP) for 1 week. The respiratory therapist examines the patients at weekly intervals by checking the diary card and measuring their MIP each time. The resistance is modified each session according to their 25-30% of their MIP measured.
Patients allocated to FES arm will receive standard medical treatment and will be trained in a FES program of both legs by a physiotherapist for 45 minutes a day, 2 days per week for a total of 12 weeks. Eight adhesive electrodes are positioned on the skin over the quadriceps and gastrocnemius muscles of both legs. The stimulator is configured to deliver a direct electrical current at 25 Hz for 5 seconds followed by a 5-second rest. The intensity of the stimulation is adjusted to achieve a visible muscle contraction without discomfort.
Patients allocated to this arm will not receive any physical therapy, only standard medical treatment. They will be checked weekly by a physiotherapist who measures their maximal inspiratory mouth pressure each time.
Eligibility Criteria
You may qualify if:
- Previous history of symptomatic heart failure NYHA (New York Heart Association )functional class ≥II with Normal left ventricular ejection fraction:
- ejection fraction \>0.50 by Simpson method
- end-diastolic diameter \<60 mm
- Structural heart disease:
- left ventricle hypertrophy/left atrial enlargement and/or
- diastolic dysfunction estimated by 2D echocardiography
- Previous admission for acute heart failure
- Clinical stability, without hospital admissions in the past 3 month
You may not qualify if:
- Perform a valid baseline exercise test
- Significant primary moderate to severe valvular disease
- Acute coronary syndrome or cardiac surgery within the previous three months
- Signs of ischemia during cardiopulmonary exercise testing
- Significant primary pulmonary disease; including pulmonary arterial hypertension, chronic thromboembolic pulmonary disease or chronic obstructive pulmonary disease
- Any other comorbidity with an expectancy of life less than one year
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universitat Jaume Ilead
- Instituto de Investigacion Sanitaria INCLIVAcollaborator
- Hospital Clínico Universitario de Valenciacollaborator
Study Sites (1)
Hospital clínico universitario de Valencia
Valencia, 46010, Spain
Related Publications (3)
Palau P, Dominguez E, Nunez E, Schmid JP, Vergara P, Ramon JM, Mascarell B, Sanchis J, Chorro FJ, Nunez J. Effects of inspiratory muscle training in patients with heart failure with preserved ejection fraction. Eur J Prev Cardiol. 2014 Dec;21(12):1465-73. doi: 10.1177/2047487313498832. Epub 2013 Jul 17.
PMID: 23864363BACKGROUNDPalau P, Nunez E, Dominguez E, Sanchis J, Nunez J. Physical therapy in heart failure with preserved ejection fraction: A systematic review. Eur J Prev Cardiol. 2016 Jan;23(1):4-13. doi: 10.1177/2047487314562740. Epub 2014 Dec 8.
PMID: 25488549BACKGROUNDPalau P, Dominguez E, Lopez L, Ramon JM, Heredia R, Gonzalez J, Santas E, Bodi V, Minana G, Valero E, Mollar A, Bertomeu Gonzalez V, Chorro FJ, Sanchis J, Lupon J, Bayes-Genis A, Nunez J. Inspiratory Muscle Training and Functional Electrical Stimulation for Treatment of Heart Failure With Preserved Ejection Fraction: The TRAINING-HF Trial. Rev Esp Cardiol (Engl Ed). 2019 Apr;72(4):288-297. doi: 10.1016/j.rec.2018.01.010. Epub 2018 Mar 16. English, Spanish.
PMID: 29551699DERIVED
Study Officials
- PRINCIPAL INVESTIGATOR
Patricia Palau, M.D., PhD
Universitat Jaume I
- STUDY DIRECTOR
Eloy Domínguez, M.D
Universitat Jaume I
- STUDY CHAIR
Julio Núñez, M.D., PhD
Universitat de Valencia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 1, 2015
First Posted
December 23, 2015
Study Start
October 1, 2015
Primary Completion
January 1, 2017
Study Completion
March 1, 2017
Last Updated
May 18, 2017
Record last verified: 2017-05